MD Anderson Cancer Center institutional guidelines for DLI starting dose. DLI starting dose should be selected based on donor and graft type. If DLI is administered earlier than 6 months after transplant, the starting cell dose should be adjusted on a case-by-case basis to minimize the risk of GvHD. DLI is repeated every alternating cycle of HMA therapy, escalating cell doses incrementally in 0.5 log steps. q, every; w, weeks.